AIM
ABMD

Artemis Investment Management’s Abiomed Inc ABMD Stock Holding History

Artemis Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-14,075
Closed -$4.58M – 303
2018
Q4 		$4.58M Buy
14,075
+1,354
+11% +$470K 0.06% 217
2018
Q3 		$5.72M Buy
12,721
+301
+2% +$119K 0.06% 239
2018
Q2 		$5.08M Buy
12,420
+976
+9% +$354K 0.07% 199
2018
Q1 		$3.33M Sell
11,444
-18,654
-62% -$4.73M 0.05% 192
2017
Q4 		$5.64M Sell
30,098
-8,470
-22% -$1.58M 0.09% 172
2017
Q3 		$6.5M Buy
38,568
+8,267
+27% +$1.25M 0.13% 155
2017
Q2 		$4.34M Buy
30,301
+11,217
+59% +$1.51M 0.11% 164
2017
Q1 		$2.39M Buy
19,084
+10,516
+123% +$1.22M 0.06% 167
2016
Q4 		$965K Sell
8,568
-2,627
-23% -$304K 0.03% 201
2016
Q3 		$1.44M Buy
+11,195
New +$1.34M 0.04% 179
2015
Q3 		– Sell
-15,640
Closed -$1.03M – 248
2015
Q2 		$1.03M Buy
+15,640
New +$1.04M 0.03% 179

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Artemis Investment Management's ABMD Position: Q1 2019 in Review

Artemis Investment Management sold out of Abiomed Inc (ABMD) in Q1 2019, closing a stake of 14,075 shares — an estimated $4.58M sold.

Artemis Investment Management first reported a position in ABMD in Q2 2015 and held it in 11 quarters. The position peaked at $6.5M in Q3 2017. 559 funds tracked by Wall St. Rank hold ABMD as of Q1 2019.

  • Artemis Investment Management reported no remaining Abiomed Inc position as of Q1 2019 after selling out during the quarter.
  • Artemis Investment Management sold 14,075 Abiomed Inc shares in Q1 2019, an estimated $4.58M.
  • Artemis Investment Management first reported a position in Abiomed Inc in Q2 2015 and held it in 11 quarters.
  • Artemis Investment Management's Abiomed Inc position peaked at $6.5M in Q3 2017.
  • 559 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2019.

Based on Artemis Investment Management's 13F filing for Q1 2019, filed 15 May 2019.